Back to Search Start Over

NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor.

Authors :
Meng Zhang
Zhenyong Zhang
Xin Tian
Enchong Zhang
Yichun Wang
Jun Tang
Jianzhu Zhao
Source :
Frontiers in Pharmacology; 2023, p01-16, 16p
Publication Year :
2023

Abstract

Tumorigenesis and tumor development are closely related to the abnormal regulation of ubiquitination. Neural precursor cell expressed developmentally downregulated 4-like (NEDD4L), an E3 ubiquitin ligase critical to the ubiquitination process, plays key roles in the regulation of cancer stem cells, as well as tumor cell functions, including cell proliferation, apoptosis, cell cycle regulation, migration, invasion, epithelial--mesenchymal transition (EMT), and tumor drug resistance, by controlling subsequent protein degradation through ubiquitination. NEDD4L primarily functions as a tumor suppressor in several tumors but also plays an oncogenic role in certain tumors. In this review, we comprehensively summarize the relevant signaling pathways of NEDD4L in tumors, the regulatory mechanisms of its upstream regulatory molecules and downstream substrates, and the resulting functional alterations. Overall, therapeutic strategies targeting NEDD4L to treat cancer may be feasible. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16639812
Database :
Complementary Index
Journal :
Frontiers in Pharmacology
Publication Type :
Academic Journal
Accession number :
173801959
Full Text :
https://doi.org/10.3389/fphar.2023.1291773